Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2026 ,inter alia, to consider and approve SURAKSHA DIAGONISTIC LIMITED has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to inter-alia, consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half-year ended 30th September, 2026.

Date: 05th November, 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra - Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 544293 Scrip Symbol: SURAKSHA Dear Sir / Ma’am, Sub: Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 10th November, 2026, at the registered office of the Company, to inter-alia, consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half-year ended 30th September, 2026. Further, in continuation to our intimation letter dated Monday, September 28, 2026, regarding closure of trading window for the aforesaid purpose, and in accordance with the Company's Internal Code of Conduct for Prohibition of Insider Trading, framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company which was closed from Thursday, 01st October, 2026 for all the directors, KMP’s, designated persons, employees, connected persons and their immediate relatives shall re-open after the expiry of 48 hours from the date of declaration of the said Financial Results. Please note that this information is also available at the website of the Company at www.surakshanet.com. We request you to take the above on record. Thanking you. For Suraksha Diagnostic Limited Shreya Arora Company Secretary & Compliance Officer Membership No.: ACS No. 30892 Suraksha Diagnostic Limited CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750